Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
STIM1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
KPNA4 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
MIR1182 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
EP400 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
TMTC3 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ERICH1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
R3HCC1L - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
XPO4 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
CAMK2D - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
NUDCD2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
CTNNA1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
OXLD1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
TSR1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
DOT1L - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
TMEM41B - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
LOC100507424 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SEC22A - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ATP5SL - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
OGFOD1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
LRFN1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on